Cat. No.: DIA-0243334
Product Information | |
---|---|
CAS No. | 1338574-83-6 |
Formula | C28H24N2O3 |
Molecular Weight | 436.50 |
SMILES | O=C(C1=CC=C(C2=CC=C(OC(N(CC3=CC=CC(C4=CC=CC=C4)=C3)C)=O)C=C2)C=C1)N |
Target | MAGL |
Product Description | WWL123, a carbamate-based compound, is a potent and selective ABHD6 inhibitor. WWL123 can be used for research of inflammation, metabolic disorders (obesity and type II diabetes mellitus) and epilepsy. |
Format & Storage | |
---|---|
Format | Solid |
Color | White to off-white |
Purity | ≥98.0% |
Shipping | Room temperature in the continental U.S. Other areas may vary. |
Storage | Powder: -20°C, 3 years In solvent: -80°C, 6 months; -20°C, 1 month |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.